ARTHEx Biotech Email Format
Biotechnology ResearchValencian Community, Spain11-50 Employees
ARTHEx Biotech is a Valencia, Spain-based biotechnology research company that originated as a spin-off from the University of Valencia. It concentrates on the research and development of oligonucleotide therapies that modulate microRNAs to address diseases with unmet medical needs. The company has developed a proprietary platform that enables rapid and flexible creation of microRNA-modulating oligonucleotides designed to reach relevant tissues in pharmacological quantities. Its lead investigational product, ATX-01, is an antimiR in development for Myotonic Dystrophy Type 1, an orphan disease lacking approved treatments, and it targets microRNA-23b involved in disease pathogenesis. ARTHEx employs 11-50 people and is based at 9 Catedrático Agustín Escardino, Paterna, Valencian Community 46980, Spain; its website is https://arthexbiotech.com. It is a clinical-stage biotechnology company pursuing RNA-based therapies.